Fresenius Kabi Australia is a leading provider of Oncology compounding and pharmacy services in Australia.
Fresenius Kabi has TGA licensed facilities in Sydney, Melbourne and Brisbane. All sites are licensed to manufacture therapeutic goods under the Therapeutic Goods Act 1989, and comply with the Code of Good Manufacturing Practice (cGMP). Fresenius Kabi also holds a Pharmacy Licence and has a registered pharmacy – W.H. McCarthy Pty Ltd (trading as Pharmatel Oncology Dispensary) co-located at the Sydney facility. This enables hospitals and clinics to have all of their oncology services met by one provider. Fresenius Kabi is accredited under ISO 9001:2000 QMS (Quality Management System) standards.